Cough News and Research

RSS

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a new study in which linagliptin demonstrated statistically significant reductions in blood glucose levels (HbA1c) after 12 weeks (the study's primary endpoint) in adults with type 2 diabetes (T2D) with moderate to severe renal impairment, compared with placebo. Most patients had T2D for more than ten years (76 percent) and were on insulin (86 percent).

24 Jun 2013

Research finds that people born during whooping cough outbreaks more likely to die prematurely

People born during whooping cough outbreaks are more likely to die prematurely even if they survive into adulthood, research at Lund University in Sweden has found.

19 Jun 2013

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

Cases of pertussis, also known as whooping cough, are on the rise in the U.S., recently reaching their highest level in 50 years. The disease can be serious or even fatal to newborns who have not yet received vaccinations.

18 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Study: Vitamin C may reduce bronchoconstriction caused by exercise

Vitamin C may substantially reduce bronchoconstriction caused by exercise, says Dr. Harri Hemila from the University of Helsinki, Finland. Hemila's meta-analysis "Vitamin C may alleviate exercise-induced bronchoconstriction" was published in BMJ Open (7 June, 2013)

12 Jun 2013

Heartburn complaints in children may be due to spicy food

Did you know the number one reason children complain about chest pain is because they actually have heartburn? A lot of people believe that adults are the only ones who get it, but I have been seeing more and more children complain about heartburn, and there are some common reasons why.

7 Jun 2013

State highlights: Calif. bill would fine big employers with employees on Medi-Cal; Abortion fight set in N.Y. Senate

For years, politicians and labor unions have pilloried Wal-Mart and other large employers for paying workers so little that many qualify for government health insurance at taxpayers' expense. Now critics fear the public will get stuck with an even bigger tab as California and other states expand Medicaid as part of the federal health care law.

4 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

Report highlights successes in improving maternal health, reducing child mortality

Rapid expansion of programs to prevent HIV transmission to babies and vaccinate children show how results can be achieved in relatively little time.

1 Jun 2013

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.

31 May 2013

CREON Delayed-Release Capsules now available in US for patients with EPI

AbbVie announced that a new, higher-dose capsule of CREON (pancrelipase) Delayed-Release Capsules is commercially available in the United States. The U.S. Food and Drug Administration recently approved CREON in a 36,000 lipase-unit dose to treat patients with exocrine pancreatic insufficiency due to cystic fibrosis, swelling of the pancreas that lasts a long time (chronic pancreatitis), removal of some or all of the pancreas (pancreatectomy), or other conditions.

31 May 2013

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung function and the safety of a range of doses in patients with moderate to severe chronic obstructive pulmonary disease.

23 May 2013

Researchers find that over 40% of patients treated for COPD did not actually have the disease

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease.

23 May 2013

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for this deadly lung disease.

22 May 2013

U-M-led researchers examine factors that contribute to resurgence of pertussis

Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence.

21 May 2013

Lung Volume Reduction Coil may play key role in treatment of emphysema, study finds

A small, easily implantable device called the Lung Volume Reduction Coil may play a key role in the treatment of two types of emphysema, according to a study conducted in Europe. Results of the study indicate the beneficial effects of the device persist more than a year after initial treatment.

21 May 2013

People exposed to wood and tobacco smoke are at greater risk for developing COPD

People who are consistently exposed to both wood smoke and tobacco smoke are at a greater risk for developing chronic obstructive pulmonary disease and for experiencing more frequent and severe symptoms of the disease, as well as more severe airflow obstruction, than those who are exposed to only one type of smoke, according to the results of a new population-based study conducted by researchers in Colombia.

21 May 2013

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference in Philadelphia, PA, May 17 – 22.

20 May 2013

Tips to keep dog park visits safe, healthy for dogs and dog owners

Dog parks are a great place to socialize dogs and let them play, but they also have some hidden dangers, according to a Kansas State University veterinarian.

20 May 2013

Cough News and Research

Eisai submits BELVIQ NDS with Health Canada

Linagliptin significantly reduces blood glucose levels in T2D patients with moderate to severe renal impairment

Research finds that people born during whooping cough outbreaks more likely to die prematurely

University of Michigan poll: 61% of adults don't know when they last vaccinated against pertussis

European Commission amends marketing authorisation for Celgene's REVLIMID

Study: Vitamin C may reduce bronchoconstriction caused by exercise

Heartburn complaints in children may be due to spicy food

State highlights: Calif. bill would fine big employers with employees on Medi-Cal; Abortion fight set in N.Y. Senate

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Report highlights successes in improving maternal health, reducing child mortality

Alios begins oral dosing of ALS-8176 in Phase 1 clinical trial for RSV infection

CREON Delayed-Release Capsules now available in US for patients with EPI

Prosonix commences Phase 2 clinical study of PSX1002 for treatment of moderate to severe COPD

Researchers find that over 40% of patients treated for COPD did not actually have the disease

Genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for lung disease

U-M-led researchers examine factors that contribute to resurgence of pertussis

Lung Volume Reduction Coil may play key role in treatment of emphysema, study finds

People exposed to wood and tobacco smoke are at greater risk for developing COPD

Boehringer Ingelheim to highlight respiratory research work at ATS 2013

Tips to keep dog park visits safe, healthy for dogs and dog owners

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News